Tadatsugu Taniguchi Selected Research

Tadatsugu Taniguchi Research Topics

Disease

13	Neoplasms (Cancer) 11/2021 - 11/2006
11	Infections 07/2021 - 08/2004
11	Virus Diseases (Viral Diseases) 08/2015 - 05/2003
6	Inflammation (Inflammations) 01/2021 - 12/2005
6	Carcinogenesis 03/2016 - 11/2006
4	Colitis 01/2017 - 01/2011
3	Septic Shock (Toxic Shock Syndrome) 01/2018 - 07/2003
3	Bacterial Infections (Bacterial Infection) 12/2013 - 08/2004
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 01/2016
2	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2016
2	Bites and Stings (Sting) 09/2018 - 12/2014
2	Neoplasm Metastasis (Metastasis) 04/2017 - 12/2016
2	Stomach Neoplasms (Stomach Cancer) 03/2016 - 03/2009
2	Hypersensitivity (Allergy) 01/2011 - 11/2005
2	Bone Diseases (Bone Disease) 01/2009 - 12/2005
2	Bone Resorption 12/2005 - 02/2005
2	Shock 11/2005 - 03/2005
1	Hepatitis 09/2021
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 07/2021
1	Allergic Contact Dermatitis 01/2021
1	Sepsis (Septicemia) 01/2018
1	Ascites 04/2017
1	Dysbiosis 01/2017
1	Chronic Hepatitis B 01/2017
1	Disease Susceptibility (Diathesis) 12/2015
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2015
1	Systemic Scleroderma (Systemic Sclerosis) 12/2015
1	Endotoxemia 12/2013
1	Heart Failure 05/2011
1	Hypertrophy 05/2011
1	Fibrosis (Cirrhosis) 05/2011
1	Hypertension (High Blood Pressure) 05/2011
1	Condylomata Acuminata (Genital Wart) 08/2009
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2009
1	Papilloma (Papillomatosis) 08/2009
1	Recurrent respiratory papillomatosis 08/2009
1	Osteoporosis 01/2009
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 12/2008
1	Necrosis 03/2005

Drug/Important Bio-Agent (IBA)

11	Transcription Factors (Transcription Factor)IBA 01/2021 - 03/2005
10	CytokinesIBA 09/2021 - 05/2003
7	InterferonsIBA 09/2018 - 03/2007
6	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2021 - 02/2004
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2004
6	Interferon Type IIBA 09/2018 - 08/2004
5	DNA (Deoxyribonucleic Acid)IBA 09/2018 - 03/2005
5	Antiviral Agents (Antivirals)IBA 01/2017 - 04/2005
4	LipopolysaccharidesIBA 01/2018 - 07/2003
3	HMGB1 Protein (HMG1)IBA 01/2021 - 12/2012
3	Factor V (Coagulation Factor V)IBA 12/2015 - 02/2007
2	Pattern Recognition ReceptorsIBA 07/2021 - 07/2011
2	Interferon-betaIBA 01/2017 - 07/2003
2	Dextran SulfateIBA 01/2017 - 12/2012
2	Dinoprostone (PGE2)FDA Link 04/2016 - 03/2016
2	A-Form DNA (A-DNA)IBA 12/2013 - 10/2009
2	Nucleic AcidsIBA 07/2011 - 12/2008
2	Toll-Like Receptor 9IBA 07/2007 - 04/2005
1	Concanavalin AIBA 09/2021
1	Small Interfering RNA (siRNA)IBA 09/2021
1	Antigen Receptors (Antigen Receptor)IBA 07/2021
1	Immunologic Factors (Immunomodulators)IBA 01/2021
1	Translationally-Controlled 1 Tumor ProteinIBA 01/2021
1	Pathogen-Associated Molecular Pattern MoleculesIBA 11/2019
1	picolinamideIBA 09/2018
1	Pharmaceutical PreparationsIBA 09/2018
1	Indicators and Reagents (Reagents)IBA 09/2018
1	GlucocorticoidsIBA 01/2017
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2017
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2017
1	C-Type Lectins (C-Type Lectin)IBA 12/2016
1	mouse dectin-2IBA 12/2016
1	LipidsIBA 04/2016
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2016
1	Acetaminophen (Paracetamol)FDA LinkGeneric 04/2016
1	Myeloid Differentiation Factor 88IBA 03/2016
1	Bleomycin (Blenoxane)FDA LinkGeneric 12/2015
1	Mitochondrial DNA (mtDNA)IBA 12/2014
1	dectin 1IBA 08/2014
1	Polysaccharides (Glycans)IBA 08/2014
1	Carrier Proteins (Binding Protein)IBA 12/2013
1	Thymic Stromal LymphopoietinIBA 12/2012
1	HMGB ProteinsIBA 12/2012
1	InterleukinsIBA 05/2012
1	RNA (Ribonucleic Acid)IBA 07/2011
1	Angiotensin IIIBA 05/2011
1	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 05/2011
1	Immunoglobulin E (IgE)IBA 01/2011
1	Messenger RNA (mRNA)IBA 03/2009
1	hydroxide ionIBA 01/2009
1	Toll-Like Receptor 3IBA 12/2008
1	Interferon Regulatory FactorsIBA 03/2008
1	Interferon LambdaIBA 03/2007
1	RANK LigandIBA 12/2005
1	Interleukin-6 (Interleukin 6)IBA 03/2005
1	Interleukin-12 (IL 12)IBA 03/2005
1	LigandsIBA 02/2005
1	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 02/2005

Therapy/Procedure

8	Therapeutics 01/2021 - 01/2009
3	Immunotherapy 11/2021 - 01/2021
1	Oral Administration 08/2013